US Patent Issued to Universitat zu Koln on July 14 for "Combinations of RIPK 1 - and IKK-inhibitors for the prevention or treatment of immune diseases" (German Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,678,447, issued on July 14, was assigned to Universitat zu Koln (Germany).

"Combinations of RIPK 1 - and IKK-inhibitors for the prevention or treatment of immune diseases" was invented by Manolis Pasparakis (Cologne, Germany), Nikos Oikonomou (Cologne, Germany) and Apostolos Polykratis (Cologne, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention pertains to the treatment of diseases associated with a dysregulated immune response such as auto immune disorders, inflammatory diseases or pathological immune responses as adverse effects of medical treatments. In particular the invention provides a combined use of inhibitors of Recep...